clinical research masters ucsd

Contact CREST Office:
Email: [email protected]

Contact MAS Office:
Email: [email protected]

Our graduates are from a wide range of disciplines, and are diverse with respect to their level of training, primary degree, and background. 

What Alumni Have To Say About the Program:

Couldn’t have done it without crest!!!!!  Outstanding program, format and mentorship.  I wrote the first grant, but as i was only a fellow, the pi was my mentor.  I now feel poised to be my own pi on my own grant and am actively pursuing several avenues. 

Mimi Lukacz, MD, MAS

Great overview of clinical research - both investigator initiated and as part of collaborative studies.  This also gives clinical researchers an opportunity to meet investigators from different departments at UCSD, which allows future collaboration.  Overall a great learning experience. 

Thomas Savides, MD, MAS

This program has opened many doors for me.  The skills gained in grant writing, protocol writing, program management strategy, and outcomes identification have given me the unique opportunity to develop, implement, and evaluate new programs in the nursing department. 

Margaret B. (Scotti) Grant, RN,MAS

The CREST and Masters in Advanced Studies programs really gave me the tools to understand clinical research design and implementation.  During the program, I became Division Chief of Regional Anesthesia and Acute Pain Medicine at UCSD.  I founded the Regional Anesthesia and Acute Pain Medicine Fellowship and expanded the Division’s scope of patient care services and clinical research activities.  I was principal investigator or co-investigator on several single- and multi-center randomized clinical trials involving the innovative use of perineural local anesthetic infusions for postoperative pain control.  In 2010, I was offered and accepted a new position as Chief of the Anesthesiology and Perioperative Care Service at the VA Palo Alto Health Care System.  I am currently an Associate Professor of Anesthesia at Stanford University School of Medicine and the Co-Director of the Stanford Regional Anesthesia Fellowship Program.  I continue to run an active clinical research program focusing on the development of techniques and patient care pathways to improve postoperative pain control and other surgical outcomes. 

Edward Mariano, MD, MAS Associate Professor of Anesthesia at Stanford University School of Medicine and the Co-Director of the Stanford Regional Anesthesia Fellowship Program

In learning the basics and process of clinical research, I understand what is undertaken when I read the literature in my field of medicine. Also, I feel more powerful when deciphering study design and statistical analysis as it pertains to results/conclusions that are published. I am more able to evaluate which studies I should pay attention to and which to ignore. 

Anushirvan Minokadeh, MD, MAS

It has helped me become successful in my role in the medical device industry and has played a critical role in my career advancement. It has empowered me to be able to provide feedback in areas of Clinical Research and Post-market studies, to review abstracts/protocols etc and has sure prepared me for the real life experience. 

Khaudeja Bano, M.B.B.S, MAS Medical Director  Abbott Diagnostics Division

It gave me a foundation on clinical research, allowing me to have a solid training in clinical research methodologies, which is crucial as a clinical investigator. 

Jeffrey Lee, MD, MAS

CREST/MAS Program gave me excellent understanding of the Clinical Research process, including how to construct a protocol, understanding of regulatory requirements, bias, statistical assessments, etc. It has served me well in my medical affairs roles (mostly phase IV studies), and with my ability to assist with design and implementation of phase 3 studies. It has improved my ability to design and write meaningful clinical research. 

Ted Okerson, MD, FACP, MAS Senior Director, Global Medical Affairs, Allergan

I have not yet had a chance to start my own clinical research but I feel prepared in supervising the residents that I work with as well as moving toward starting my own research projects. 

Michelle Loose, MD, MAS

It gave me a thorough understanding of the basic terminologies, procedures, and sciences involved in conducting clinical research. 

Othman Mohammad, MD

An understanding of the different components of clinical research. The most valuable area was to meet senior researchers and to have those individuals mentor me in future projects. 

Adriana Tremoulet, MD, MAS

I am looking towards transferring from preclinical bench research to clinical research and this program has given me helpful insight into what monitoring a clinical trial entails. From budget and protocol preparation, to budget negotiation, data analysis techniques, data management and FDA audits, this program has given me a solid foundation from which to initiate a career in the clinical research arena. 

Christiane A Villescaz, MAS

The CREST program gave me a solid foundation for conducting patient-oriented clinical research and skills on describing the research methods and data analysis. These skills are crucial for me as I am getting ready for my first academic appointment. 

Milena Weinstein, MD,MAS

The Program helped me get a holistic view of the research process, an ability to analyze data using biostatistics, a greater ability to read and understand scientific papers, and time to pursue my own research endeavors. 

Alexander Ko, MD, MAS

The program gave me an introduction to the basics of research methodology. - Opportunity to network with senior faculty with successful academic careers -  Strengthened my interest in clinical research. 

Prasanthi Ramanujam, MD, MAS

Definitely gave me more confidence in my ability to design studies. Clarified many points for me. I’d taken courses on study design many years ago and this consolidated all the information. The very most useful one was Dr. Lindsay’s Epidemiology class. 

Ann Sturley, RN, MAS San Diego Hospice

The CREST Program gave me the capacity to better understand the major players in clinical and translational research and patient-centered studies; discuss the most recent advances and relevant statistical and methodological tools for effective and efficient design and conduct of clinical studies that are practice and community based; and to promote new avenues of investigation, the development of new approaches and techniques in translational and patient-centered research in my area of research interest which is nephrology. 

Rolando Claure Del Granado, MD, MAS Assistant Profesor in Nephrology at Universidad del Valle; Cochabamba–Bolivia

 ACTRI CREST 

• Who can apply? 
• If I am not with UCSD or UCSD affiliate, can I still apply to the program?
• How do I apply to the program?
• What are the admission requirements for CREST?
• What are the admissions requirements for the MAS degree program?
• When is the deadline for submitting the application?

Where do I send my application?

• Could I register for the MAS degree program after completing the all the 2-year CREST courses?

How long does it take to complete the CREST program?

How many credit units are needed to earn the mas degree.

• How much does it cost?

Who can apply?

Any doctoral candidates, postdoctoral fellows, or junior faculty who are pursuing a career in clinical or translational research can apply. Members of UCSD and its affiliates (UCSD staff, fellows, faculty, junior faculty, VA, Children's Hospital), apply through CREST.

If I am not with UCSD or a UCSD affiliate, can I still apply to the program?

Yes, you are eligible to apply through the Masters of Advanced Studies in Clinical Research degree program. Details of the Masters Degree program and fees can be found at http://clre.ucsd.edu/ .  

What are the admissions requirements for the CREST program?

Those interested in applying are encouraged to visit the CREST website , read and understand the descriptions and objectives of the courses they are interested in, review the course start and end dates, and review the overall program goals. For more information on admission, please visit the  Prospective Students page . Applicants must agree to commit to attending at least 70% of the classes for each course, and completing the majority of the homework. By the end of their first year in the CREST program, students must decide if they would like to apply for the MAS Program.

What are the admissions requirements for the Masters of Advanced Studies (MAS) in Clinical Research degree program?

Full- time UCSD Employee or Affiliate (employed by UCSD or affiliates like Rady Children’s Hosp., VA, etc) will apply through the CREST program (Track 2 – transferring to the MAS degree program after 20 units) and enjoy the discounted course fee instead of paying full MAS fee ($886/unit).  UCSD Fellows/Research Staff pay $340/unit and faculty pay $450/unit through CREST UP TO the first 20 units of the curriculum (40 total for the degree). The CREST and MAS curriculum are identical up to 20 units.

How do I apply?

UCSD and affiliates: UCSD fellows, faculty, junior faculty, VA, Children's Hospital should submit:

• CREST Program Application
• Agreement letter of primary supervisor (signed)
• Resume or Curriculum vitae
• Statement of Purpose 
• Letters of Recommendation  (3)  

Non-UCSD affiliates: please visit  http://clre.ucsd.edu/  for detailed instructions on applying for the Masters of Advanced Studies in Clinical Research program.

UCSD and affiliates: Submit CREST Program Application  online. Required documents can be sent to: CREST Program Office University of California, San Diego 9500 Gilman Drive, Mail Code 0170X La Jolla, CA  92093-0170X [email protected]

Non-UCSD affiliates: See information at http://clre.ucsd.edu/ .

CREST program application deadlines

- The registration deadlines are September 30 for the January session and April 30 for the July session

Track II students:

• Get Advanced Certificate in Clinical Research once completed the 20 unit
• Continue for Master's Degree in Clinical Research

Track I students:

• Enroll in individual courses
• Enrollment is on a space available basis i.e. will be placed on a waiting list (first come-first serve) until administering the certificate/degree students.
• Can't get Advanced Certificate in Clinical Research or continue for Master's Degree in Clinical Research.

If there are more applicants than can be accommodated for a given course, the Program Director and Co-Directors will determine which applicants will be accepted. Admission will be based on affiliation (preference given to UCSD/VA/Children's Hospital affiliates), level (preference given to fellows), expected benefit of the program to the individual (as determined by factors such as type of research and previous research experience), and date of submission of application.

Could I register for the MAS degree program after completing all of the entire 2-year CREST courses?

No,  you must decide by the end of your 1st year and/or prior to completing the 20 units (must enroll as Track II) if you are going to enroll in the degree program.

The CREST Program consists of 20 credit units of study. Coursework can be completed in 12 to 24 months of study, depending upon a participant's time to devote to the program. Students must enter the program in the winter (January) or in the summer (July) to complete the certificate program in 12 months.

The master's degree in Clinical Research consists of 40 credit units of study. Coursework can be completed in 18 to 30 months of study, depending upon a participant's time to devote to the program. Students enter the program in the winter (January)or in the summer (July) to complete the degree program in 18 months.

If I apply for the MAS degree program but then decide to leave after completing the second year, can I still receive a certificate for completing the CREST program?

Yes, you'll receive a certificate if you've completed the 20 credit units of study and passed the comprehensive exam.

How much does CREST cost?

All UCSD residents, fellows (including laboratory-based fellows), and faculty pay a discounted fee: The fee for UCSD residents and fellows is $680 per 2 unit course ($340/unit). The fee for UCSD faculty is $900 per 2 unit course ($450/unit). The fee for   Non-UCSD affiliates is $1,772 per 2 unit course ($886/unit)  The fee covers the costs for all lectures and course materials and books.

For those who are interested in the Master of Advanced Studies in Clinical Research degree, there will be additional university fees for each quarter of enrollment. Details of the Masters Degree program and fees can be found here.

• Curriculum and Course Descriptions

(RN) Registered Nurse - Pediatrics Research - 131874

Job description, #131874 (rn) registered nurse - pediatrics research.

This position is a limited position with the possibility of extension/career conversion.

Special Selection Applicants : Apply by 9/10/2024. Eligible Special Selection clients should contact their Disability Counselor for assistance.

Current UC San Diego Health CNA (NX) represented RN/NP applicants will be considered after the first 7 days of job posting. All additional applicants will be considered after 14 days of job posting, pending the status of the initial internal CNA (NX) represented applicant pool.

This position will work a hybrid schedule which includes a combination of working both onsite on Campus and remote.

DESCRIPTION

UC San Diego Health is a Magnet designated organization, which is a prestigious recognition that applies to only 10% of all U.S. hospitals. Magnet is the "gold standard" for nursing excellence and is based on strengths in five key areas, which include transformational leadership, structural empowerment, exemplary professional practice, new knowledge, innovation and improvements and empirical outcomes. UC San Diego Health has held its Magnet status since 2011.

The Department of Pediatrics is one of the largest departments within the School of Medicine with approximately 250 Faculty, 127 postdoctoral fellows (both MDs and PhDs) along with over 320 support staff (not including hospital staff). In addition, the Department has 68 clinical residents distributed across the Divisions. The missions of research, education and patient care are intertwined, and are integral to the goals of the department.

The Department manages a university-affiliated children's health system with the physicians and leadership of the University of California, San Diego (UCSD), Rady Children's Hospital, and Rady Children's Specialists of San Diego, a Medical Practice Foundation, unifying pediatric patient care, research, education and community service programs.

The Pediatric Immunization Advancement Laboratory focuses on maternal and infant vaccinations, optimizing vaccination strategies in the community setting, and improving vaccine immunity. Our global research evaluates infant immune development, responses to mucosal vaccination, and the influence of breast milk and gut microbes on immune responses. Research starts at the bed side, is taken to the bench, and then back to bed side and community. Our goal is to find strategies to improve vaccine effectiveness and protect vulnerable infants and children from infectious diseases worldwide.

Under general supervision, Research Nurse will be responsible for running COVID-19, Influenza, RSV and other vaccine research protocols. Responsibilities vary by study and may include screening potential study participants, providing informed consent, administering vaccine, following subjects in longitudinal study protocols for routine and illness visits, medical record review, having telephone contact with participants, blood draws, nasal or nasopharyngeal swabs, other specimen collection, physical exam, completing case report forms; research scheduling; interact with research team, the UCSD Human Subjects Protection Program, and study sponsors, and other research related entities as needed.

While not required, a cover letter is highly recommended when applying to this position.

MINIMUM QUALIFICATIONS

Possession of the legal requirements to practice as a Registered Nurse as determined by the California Board of Registered Nursing and six months of clinical experience.

BLS/CPR certification at time of hire with commitment to get BART within 6 months of hire date.

A minimum of two (2) years experience in pediatrics, preferably in emergency room, inpatient, NICU, or ICU setting.

Must have excellent phlebotomy, IV insertion skills with experience in pediatrics.

Experience and ability to accurately collect, record, transcribe, and synthesize clinical data.

Demonstrated experience providing a wide variety of patient care activities including patient assessment, triage, obtaining a detailed medical history and vital signs, explaining medical conditions and procedures, reviewing medications and providing health education to clients, and coordinating care with clinical medical staff.

Knowledge regarding the standard pre-test or pre-procedure instructions that patients should receive.

Knowledge of the name, abbreviation, and purpose of various diagnostic tests/procedures, including proper scheduling and completion of necessary requisitions and consents.

Demonstrated experience interacting positively, constructively, and effectively with staff, physicians, patients, and the general public.

Excellent organizational skills with the ability to effectively and efficiently coordinate clinical and data activities for the enrollment and retention of patients on clinical trials.

Experience maintaining patient confidentiality and communicating (verbally and written) with patients, staff, and physicians with professionalism, sensitivity, and discretion.

Proficient at word processing, spreadsheet, and E-mail with experience producing reports, profiles, correspondence, graphs, and spreadsheets to generate and track required data.

Experience working independently and prioritizing tasks to meet strict guidelines and deadlines.

Experience performing effectively under conditions of high workload and frequent interruptions.

Ability to draw blood, start IV lines, and administer vaccines via all routes.

Must have reliable transportation and willing to perform home visits.

PREFERRED QUALIFICATIONS

Demonstrated experience with clinical research activities and guidelines related to consent, ethical conduct and protection of human subjects.

Demonstrated experience in operation and coordination of clinical trials or studies.

Experience reading and interpreting clinical research protocols and research policies and procedures.

Experience in providing care to a broad range patients.

Knowledge of and ability to communicate and ensure compliance of current UCSD Medical Center and Research policies and procedures. Knowledge of UCSD Medical Center, JCAHO, and Title XXII hospital licensing regulations.

Intermediate skills in using quality assessment and quality improvement methods.

SPECIAL CONDITIONS

Employment is subject to a criminal background check and pre-employment physical.

Must be willing to work a flexible schedule including occasional early mornings, evenings, and weekends.

Current State of California Registered Nurse (RN) license.

Pay Transparency Act

Annual Full Pay Range: $123,902 - $173,659 (will be prorated if the appointment percentage is less than 100%)

Hourly Equivalent: $59.34 - $83.17

Factors in determining the appropriate compensation for a role include experience, skills, knowledge, abilities, education, licensure and certifications, and other business and organizational needs. The Hiring Pay Scale referenced in the job posting is the budgeted salary or hourly range that the University reasonably expects to pay for this position. The Annual Full Pay Range may be broader than what the University anticipates to pay for this position, based on internal equity, budget, and collective bargaining agreements (when applicable).

If employed by the University of California, you will be required to comply with our Policy on Vaccination Programs, which may be amended or revised from time to time. Federal, state, or local public health directives may impose additional requirements. If applicable, life-support certifications (BLS, NRP, ACLS, etc.) must include hands-on practice and in-person skills assessment; online-only certification is not acceptable.

UC San Diego Health Sciences is comprised of our School of Medicine, Skaggs School of Pharmacy and Pharmaceutical Sciences, The Herbert Wertheim School of Public Health and Human Longevity Science, and our Student Health and Well-Being Department. We have long been at the forefront of translational - or "bench-to-bedside" - research, transforming patient care through discovery and innovation leading to new drugs and technologies. Translational research is carried out every day in the hundreds of clinical trials of promising new therapies offered through UC San Diego Health, and in the drive of our researchers and clinician-scientists who are committed to having a significant impact on patient care. We invite you to join our team!

Applications/Resumes are accepted for current job openings only. For full consideration on any job, applications must be received prior to the initial closing date. If a job has an extended deadline, applications/resumes will be considered during the extension period; however, a job may be filled before the extended date is reached.

To foster the best possible working and learning environment, UC San Diego strives to cultivate a rich and diverse environment, inclusive and supportive of all students, faculty, staff and visitors. For more information, please visit UC San Diego Principles of Community .

UC San Diego is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age or protected veteran status.

For the University of California’s Affirmative Action Policy please visit: https://policy.ucop.edu/doc/4010393/PPSM-20 For the University of California’s Anti-Discrimination Policy, please visit: https://policy.ucop.edu/doc/1001004/Anti-Discrimination

UC San Diego is a smoke and tobacco free environment. Please visit smokefree.ucsd.edu for more information.

UC San Diego Health maintains a marijuana and drug free environment. Employees may be subject to drug screening.

Application Instructions

Please click on the link below to apply for this position. A new window will open and direct you to apply at our corporate careers page. We look forward to hearing from you!

Share This Page

Posted : 8/27/2024

Job Reference # : 131874

JOIN OUR TALENT COMMUNITY

Interested in working at UC San Diego and UC San Diego Health but can't find a position that's right for you? Submit your resume to our Talent Community to be considered for future opportunities that may align with your expertise. Please note, by joining our Talent Community, you are not applying for a position with UC San Diego Campus and Health. Rather, this is an additional way for our Talent Acquisition team to find candidates with specific credentials, if an opportunity arises. You are still encouraged to regularly check back on our career site or sign up for Job Alerts to apply for openings that are a match for your background.

• Career Sites by Recruiting.com

Borderzone Breakthrough: A New Source of Cardiac Inflammation

• Ioana Patringenaru - [email protected]

Published Date

Share this:, article content.

Ischemic heart disease is the most common cause of death in the world. It begins with a “heart attack”, also known as a myocardial infarction (MI), which causes part of the heart to die due to inadequate coronary blood flow. This leads to vigorous inflammation, heart wall remodeling, and heart failure.

Anti-inflammatory drugs have been surprisingly ineffective at preventing heart failure. As a consequence, they are not a routine part of post-MI care. However, it is possible that the most potent molecular and cellular inflammation targets have yet to be discovered.

In the Aug. 28, 2024 issue of Nature, researchers from University of California San Diego in the laboratory of Dr. Kevin King, associate professor of bioengineering and medicine, and a cardiologist at the Sulpizio Cardiovascular Center, report the discovery of a novel mechanism of cardiac inflammation that may expand therapeutic opportunities to prevent heart attacks from becoming heart failure.

Inflammation after MI is classically credited to professional immune cells like neutrophils and macrophages that infiltrate the infarcted heart and respond to molecules in the debris of dying cells. So the team was surprised when they discovered that the proinflammatory “type I interferon (IFN) response” was activated, not in the infarct where immune cells were concentrated, but instead in the borderzone, surrounding the infarct.

The borderzone has been a fascinating yet understudied area of the infarcted heart. It is where surviving heart muscle cells attempt to stabilize and even proliferate after being disconnected from their dying neighbor cells. Unfortunately, the borderzone has proven a challenging region to study because it is not easily isolated from the rest of the heart. Researchers overcame this obstacle using methods they recently reported based on single cell RNAseq and spatial transcriptomics where cells of the borderzone are recognized based on their patterns of gene expression ( https://www.nature.com/articles/s44161-022-00160-3 ).

To determine which cell type initiates borderzone inflammation, the team created a library of conditional knockout mice, each unable to initiate IFN signaling in a different cell type. To their surprise, heart muscle cells called cardiomyocytes emerged as the dominant initiators of borderzone IFN signaling. They found that mechanically stressed cardiomyocytes in the borderzone frequently suffered nuclear envelope rupture, which allowed escape of nuclear DNA and sensing by cytosolic DNA sensors, leading to activation of IFN signaling. This in turn caused mechanical weakening of the heart wall and made it vulnerable to dilation, thinning, and rupture, providing a mechanistic explanation for the team’s previous reported observation that mice lacking IFN responses exhibited improved survival after MI ( https://www.nature.com/articles/nm.4428 ).

“In the hospital, we care for patients with heart attacks and heart failure every day. New therapeutic targets for MI with the potential to prevent development of heart failure are incredibly important, said Dr. King, senior author of the study an on the faculty in the Shu Chien Gene Lay Department of Bioengineering and the Division of Cardiology at UC San Diego.

Many questions remain, however the newly reported findings suggest that limiting mechanical stress at the borderzone, inhibiting DNA sensing, and preventing type I IFN signaling may represent new opportunities for patients to avoid development of heart failure after MI.

Funding support for the study came, in part, from the NIH DP2 New Innovator Award.

Nature paper:  Spatially clustered type I interferon responses at injury borderzones

{/exp:typographee}

You May Also Like

At the ready: a day in the life of a trauma surgeon, opentopography receives $4 million to support ai-ready access to topographic data for research and education, uc san diego’s mandeville art gallery receives grant from new york-based teiger foundation, stay in the know.

Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.

You have been successfully subscribed to the UC San Diego Today Newsletter.

Campus & Community

Arts & culture, visual storytelling.

• Media Resources & Contacts

Signup to get the latest UC San Diego newsletters delivered to your inbox.

Award-winning publication highlighting the distinction, prestige and global impact of UC San Diego.

Popular Searches: Covid-19   Ukraine   Campus & Community   Arts & Culture   Voices

• For Journalists
• News Releases
• Latest Releases
• News Release

Northwestern receives $55 million to advance health research

Largest active grant at Northwestern to fund clinical, translational research hub

Media Information

• Embargo date: August 29, 2024 10:00 AM CT
• Release Date: August 29, 2024

Media Contacts

Kristin Samuelson

• (847) 491-4888
• Email Kristin
• Funding will enable discoveries for diverse populations to go from lab to clinical care settings
• Will translate scientific research to treatments, therapies that can improve patients’ quality of life
• Institute will infuse implementation-science methods into research to make public health improvements more scalable
• ‘Clinical and translational research does not happen in a bubble’

CHICAGO --- The Northwestern University Clinical and Translational Sciences ( NUCATS ) Institute has received $55 million in National Institutes of Health (NIH) funding to accelerate the development, evaluation and implementation of improved health care interventions.

The seven-year award is the largest current research grant at Northwestern and extends a legacy of NIH funding that began when the institute launched in 2008.

The NUCATS Institute helps translate novel discoveries from the laboratory to routine clinical care, leading to treatments and therapies that can extend and improve the quality of life for patients. This is a process that remains slow, complex and labor intensive. NUCATS provides scientists at its four health system partners (Northwestern; Ann and Robert H. Lurie Children's Hospital of Chicago and its Stanley Manne Children’s Research Institute; Shirley Ryan AbilityLab; and Northwestern Medicine) with consultative resources and expertise to accelerate how quickly transformative scientific discoveries reach patients and communities.

“Clinical and translational research does not happen in a bubble. It requires dedicated investigators and members of the public to advance human health,” said Dr. Richard D’Aquila , associate vice president of research and senior associate dean for clinical and translational research at Northwestern University Feinberg School of Medicine. “With generous support from the NIH and Northwestern, we will continue to work alongside our exceptional coalition of community and health system partners to help build a better framework for innovating and implementing discoveries in ever more inclusive ways.”

NUCATS is led by principal investigators D’Aquila; Sara Becker , the Alice Hamilton Professor of Psychiatry; and Dr. Clyde Yancy , chief of cardiology at Feinberg.

“The collection of extraordinary faculty and staff who will manage this iteration of NUCATS is a testament to the transformational mindsets held by the institute’s leadership,” said  Dr. Eric G. Neilson , vice president for medical affairs and Lewis Landsberg Dean of Feinberg. “This funding allows us to further advance our mission to improve human health by investigating the mechanisms that drive the translation of discoveries toward real-world treatments.”

NUCATS and the multiple-principal investigator team will develop, evaluate and disseminate more effective health interventions to more patients more quickly following these three specific aims:

• Include: Cultivate a culture of inclusive excellence as they expand their workforce, partnerships and research participants, including those historically underrepresented in biomedical science, to optimize the benefits of translation for all;
• Innovate: Support innovation to accelerate and transform translation; and
• Implement: Infuse implementation-science methods into clinical research.

The grant is awarded by the NIH's Clinical and Translational Science Awards (CTSA) Program , which supports a national network of medical institutions that speed the translation of research discoveries into improved care. The institute also is positioned to infuse implementation-science methods into work across the translational continuum to improve public health and meet the needs of all.

“Implementation science can help us accelerate and catalyze the uptake of evidence-based practice into routine clinical care,” said Becker, director of Northwestern’s Center for Dissemination and Implementation Science. “Northwestern is a national leader in this space. The NUCATS Institute will become a model CTSA hub that advances inclusive, innovative and implementable solutions to the evolving challenges that impede scalable public health progress.”

Yancy’s research in cardiology and health disparities addresses optimal treatment of heart failure. In a seminal contribution, he revealed the predominant cause of heart failure among Black people is hypertension rather than the ischemic heart disease, which is most often the commonly accepted cause in non-Black patients. His groundbreaking work informed how to optimize treatment strategies for Black patients, including the first-ever FDA-approved therapy specifically for Black patients.

“Diversity in the biomedical workforce is more than representativeness, it is rather about excellence, diverse ideas and unique strategies that will enrich our ability to provide care for the entire population,” said Yancy, vice dean for diversity and inclusion at Feinberg. “By addressing inequities with intentionality, we are positioned to understand and then overcome persistent systemic limitations that hurt those underrepresented and underserved populations and, in turn, impair best health for everyone. We commit to responsibly and courageously leading the path to inclusive excellence and belonging.”

Since launching in 2008, the NUCATS has supported more than 3,500 academic publications and annually facilitates more than $1 million in competitive pilot research projects that seed new NIH applications.

The new CTSA activities are funded by the National Center for Advancing Translational Sciences (grant UM1TR005121) , which is part of the NIH.

• Skip to main content
• Skip to footer

Samantha Hurst , PhD